EVMN

Evommune, Inc. Common Stock (EVMN)

About Evommune, Inc. Common Stock (EVMN)

Evommune, Inc. is a clinical-stage biotechnology company. It engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pena, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Palo Alto, CA.

Details

Daily high

$14.53

Daily low

$14.07

Price at open

$14.09

52 Week High

$33.20

52 Week Low

$10.47

Market cap

517.2M

Dividend yield

Volume

322,426

Avg. volume

506,614

P/E ratio

-5.04

Evommune, Inc. Common Stock News